Research and Policy Repository

Comparison of referral rates and costs using fibrosis-4 and enhanced liver fibrosis (ELF) testing strategies for initial evaluation of metabolic dysfunction-associated steatotic liver disease (MASLD) in a Veteran population

Abstract: Background: Global metabolic dysfunction-associated steatotic liver disease (MASLD) prevalence is estimated at 30% and projected to reach 55.7% by 2040. In the Veterans …

Physical Health Peer reviewed

Incidence of cirrhosis and hepatocellular carcinoma among Veterans with noncirrhotic metabolic dysfunction-associated fatty liver disease

Abstract: Background and Aims: Despite the high prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD), the long-term incidence of cirrhosis or hepatocellular …

Physical Health Peer reviewed